About Us
The Radiological Chemistry Laboratory carries out research on the development
of image enhancement agents and radiopharmaceuticals for therapy. The laboratory
is in the Division of Radiological Sciences in the Mallinckrodt Institute,
Department of Radiology, Washington University Medical School. The laboratory
operates three cyclotrons for radionuclide production and maintains
state-of-the-art equipment for synthesis, separation and quality control of
agents for imaging and therapy. Research is carried out in development of
both inorganic and organic compounds for positron emission tomographic (PET),
single photon emitted tomographic (SPECT) and magnetic resonance (MR) imaging
applications. Radiopharmaceuticals are also developed for the investigation
of targeted radiotherapy. The laboratory is supported by Federal grants of
approximately $2,000,000 direct costs as well as funding from Foundations
(Whitaker Foundation) and several industrial collaborators.
